摘要
多囊卵巢综合征(PCOS)的药物治疗主要通过调整内分泌和代谢失调达到个体化治疗目的,常用药物包括达英-35、二甲双胍及克罗米芬等。本文综述PCOS的内分泌失调和代谢紊乱的临床表现与发病机制,以及药物治疗进展。
The medication of polycystic ovary syndrome (PCOS), which is primarily through adjusting endocrine and metabolic disorder to reach individualized therapy purpose, includes diane-35, metformin and clomifene. This article reviews the endocrine and metabolic disorder, their pathophysiological mechanism and the advances in drug treatment for PCOS.
出处
《世界临床药物》
CAS
2012年第12期712-717,共6页
World Clinical Drug